Swiss National Bank Has $3.53 Million Stock Holdings in Embecta Corp. (NASDAQ:EMBC)

Swiss National Bank increased its position in shares of Embecta Corp. (NASDAQ:EMBC – Get Rating) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 139,720 shares of the company’s stock after acquiring an additional 2,700 shares during the quarter. Swiss National Bank owned about 0.24% of Embecta worth $3,534,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Union Heritage Capital LLC acquired a new position in Embecta in the third quarter valued at about $29,000. Laurel Wealth Advisors LLC acquired a new position in Embecta in the third quarter valued at about $29,000. Lazard Asset Management LLC acquired a new position in Embecta in the third quarter valued at about $31,000. Russell Investments Group Ltd. acquired a new position in Embecta in the third quarter valued at about $32,000. Finally, IFP Advisors Inc acquired a new position in Embecta in the third quarter valued at about $183,000. Institutional investors and hedge funds own 93.45% of the company’s stock.

Embecta Trading Down 5.0 %

NASDAQ:EMBC opened at $27.05 on Monday. Embecta Corp. has a 1-year low of $22.30 and a 1-year high of $36.64. The business’s 50-day moving average price is $28.83 and its two-hundred day moving average price is $29.21. The firm has a market capitalization of $1.55 billion and a price-to-earnings ratio of 16.70.

Embecta Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 13th. Shareholders of record on Monday, May 29th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, May 25th. This represents a $0.60 annualized dividend and a dividend yield of 2.22%. Embecta’s dividend payout ratio (DPR) is currently 37.04%.

About Embecta

(Get Rating)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally.